Leonetti A - Search Results

1

Outcome and Safety of Sorafenib in Metastatic Renal Cell Carcinoma Dialysis Patients: A Systematic Review.

Leonetti A, Bersanelli M, Castagneto B, Masini C, Di Meglio G, Pellegrino B, Buti S. Leonetti A, et al. Clin Genitourin Cancer. 2016 Aug;14(4):277-83. doi: 10.1016/j.clgc.2016.01.010. Epub 2016 Jan 28. Clin Genitourin Cancer. 2016. PMID: 26899142 Review.

2

Primary Retroperitoneal Cystoadenocarcinoma: A Systematic Review.

Pellegrino B, Sikokis A, Bersanelli M, Leonetti A, Leonardi F, Di Meglio G, Buti S. Pellegrino B, et al. Among authors: leonetti a. Gynecol Obstet Invest. 2016;81(5):385-93. doi: 10.1159/000446954. Epub 2016 Jun 17. Gynecol Obstet Invest. 2016. PMID: 27309542 Review.

3

Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy.

Buti S, Leonetti A, Dallatomasina A, Bersanelli M. Buti S, et al. Among authors: leonetti a. Core Evid. 2016 Sep 1;11:23-36. doi: 10.2147/CE.S98687. eCollection 2016. Core Evid. 2016. PMID: 27621699 Free PMC article. Review.

4

"Finding NEMO" in NRAS-mutant melanoma: a step towards a sequential strategy?

Bersanelli M, Leonetti A, Buti S, Michiara M. Bersanelli M, et al. Among authors: leonetti a. Lancet Oncol. 2017 Jun;18(6):e298. doi: 10.1016/S1470-2045(17)30349-2. Lancet Oncol. 2017. PMID: 28593853 No abstract available.

5

Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma.

Leonetti A, Leonardi F, Bersanelli M, Buti S. Leonetti A, et al. Ther Clin Risk Manag. 2017 Jun 30;13:799-806. doi: 10.2147/TCRM.S126910. eCollection 2017. Ther Clin Risk Manag. 2017. PMID: 28721060 Free PMC article. Review.

6

The link between calcitriol and anticancer immunotherapy: vitamin D as the possible balance between inflammation and autoimmunity in the immune-checkpoint blockade.

Bersanelli M, Leonetti A, Buti S. Bersanelli M, et al. Among authors: leonetti a. Immunotherapy. 2017 Nov;9(14):1127-1131. doi: 10.2217/imt-2017-0127. Immunotherapy. 2017. PMID: 29067883 No abstract available.

7

Adjuvant tyrosine kinase inhibitors for renal cell carcinoma? No, thank you (at least for the present).

Leonetti A, Zielli T, Buti S. Leonetti A, et al. Future Oncol. 2018 Sep;14(22):2223-2224. doi: 10.2217/fon-2018-0304. Epub 2018 Aug 1. Future Oncol. 2018. PMID: 30064274 No abstract available.

8

Radiotherapy for the treatment of distant nodes metastases from oligometastatic urothelial cancer: A retrospective case series.

Leonetti A, D'Abbiero N, Baldari G, Andreani S, Ruffini L, Viansone AA, Buti S. Leonetti A, et al. Int J Urol. 2018 Oct;25(10):879-886. doi: 10.1111/iju.13773. Epub 2018 Aug 13. Int J Urol. 2018. PMID: 30103254

9

Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives.

Facchinetti F, Bordi P, Leonetti A, Buti S, Tiseo M. Facchinetti F, et al. Among authors: leonetti a. Drug Des Devel Ther. 2018 Sep 10;12:2857-2873. doi: 10.2147/DDDT.S124380. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30237696 Free PMC article. Review.

10

Role of stereotactic body radiation therapy for the management of renal cell carcinoma: tailoring treatment in the era of the "embarrassment of riches".

Buti S, Leonetti A, Lattanzi E, D'Abbiero N, Bersanelli M. Buti S, et al. Among authors: leonetti a. Ann Transl Med. 2019 Jul;7(Suppl 3):S106. doi: 10.21037/atm.2019.05.04. Ann Transl Med. 2019. PMID: 31576313 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters